2020
DOI: 10.1016/j.jaad.2019.12.049
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 21 publications
0
23
0
Order By: Relevance
“…MMS with standard H&E provides 98% to 99% cure rates for primary cSCC with zero (T1) to one (T2a) high-risk features based on Brigham and Women's Hospital staging. 3 Local recurrence rates for high-risk cSCC treated with MMS range between 4% (AJCC8 T3) and 6% (Brigham and Women's Hospital staging T2b/3). 4 However, PCK utilization rate during MMS is unknown, and data on patient outcomes for cSCC treated with MMS plus PCK is lacking.…”
Section: Discussionmentioning
confidence: 99%
“…MMS with standard H&E provides 98% to 99% cure rates for primary cSCC with zero (T1) to one (T2a) high-risk features based on Brigham and Women's Hospital staging. 3 Local recurrence rates for high-risk cSCC treated with MMS range between 4% (AJCC8 T3) and 6% (Brigham and Women's Hospital staging T2b/3). 4 However, PCK utilization rate during MMS is unknown, and data on patient outcomes for cSCC treated with MMS plus PCK is lacking.…”
Section: Discussionmentioning
confidence: 99%
“…Other surgical modalities like Moh's surgery, curettage, or cryosurgery are not recommended for Marjolin's ulcer by many reports because of the high incidence of deep tumour invasion. 15 , 50 , 51 On the other hand, Copcu's study for small lesions, less than 2 cm, presented 31 cases managed by Moh's micrographic surgery that showed a 92% cure rate. 20 , 34 However, Moh's surgery has drawbacks of relatively prolonged surgical time, and unfeasibility of its facilities or experts in every centre.…”
Section: Discussionmentioning
confidence: 99%
“…In their study, the LRR was 2.6% in patients with primary SCC and 5.9% in patients with previously recurrent SCC [ 54 ]. Xiong et al conducted a retrospective study evaluating the outcomes of patients with T2a SCC who were treated with WLE or MMS [ 55 ]. They found that the LRR was significantly higher in those treated with WLE (4.0%) than in those treated with MMS (1.2%).…”
Section: Surgical Margin Of Primary Tumorsmentioning
confidence: 99%